BASF India to Close Dahej Plants

BASF India Limited has announced the board's approval to close specific manufacturing plants at its Dahej facility. The sulfation and low-temperature reactor plants, part of the Nutrition & Care segment, are slated for closure by the end of calendar year 2026, pending necessary approvals.

What just happened

The company will cease operations at its sulfation and low-temperature reactor plants in Dahej. This decision stems from operational challenges and strategic realignments within the Care Chemicals business.

Why this matters

These plants contributed Rs 542 crore, approximately 4%, to BASF India's projected revenue for FY 2025-26. The closure is a strategic move to address overcapacity and margin pressures in a changing market.

The backstory

BASF India's Care Chemicals business is facing evolving market dynamics, overcapacity in certain segments, and high operating costs leading to margin pressure. This restructuring is a response to these industry headwinds.

What changes now

While these specific plants will close, BASF India will continue to manufacture, import, and sell other products within its Care Chemicals portfolio to meet customer demand in India. The company aims to protect its margins by exiting less profitable product lines.

Risks to watch

Investors should monitor the impact of this capacity reduction on overall segment margins and the company's ability to pivot its product mix effectively.

Peer comparison

Information on specific peer company actions regarding similar plant closures or restructurings is not provided in the filing.

Context metrics (time-bound)

The affected plants represented Rs 542 crore or 4% of BASF India's projected revenue for FY 2025-26. The closure is expected by the end of calendar year 2026.

What to track next

Investors should observe the company's performance in the Care Chemicals segment post-restructuring and any updates on strategic adjustments to its product offerings and manufacturing footprint.